medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2020, Number 6

<< Back Next >>

Rev ADM 2020; 77 (6)

Phenytoin induceded gingival enlargement

Córdova-García, Diana P; Zatarain, Gilberto; Reyes, Alejandra; Díaz, Enrique; Pietshmann, Ángeles

Language: Spanish
References: 11
Page: 316-320
PDF size: 304.35 Kb.


ABSTRACT

Gingival enlargement means the increase in mass and volumen of the gingival tissue. It is considered a benign condition of the oral cavity, usually of routine management, wich can be regulated with simple measures of biofilm control. The gingival enlargement can be produced by diverse clinical conditions, hereditary deficient oral higiene or drugs. Epilepsy affects 1% of the world population and requires the use of antiepileptic or anticonvulsant drugs to achieve its control, within these phenytoin acts as selective blocker or voltage – sensitive sodium channels and is one of the most used grugs for its ability to control focal and generalized crises. Phenytoin has been linked to gingival enlargement as one of its adverse effects which is included within the drug diseases induced in the oral cavity. The objective of this article is to provide the necessary information on the correct managment of patients with gingival enlargemen produced by phenytoins and at the same time to know the consequences of these drugs in the oral cavity.


REFERENCES

  1. Ahmed S, Bey A, Hashmi S, Yadav S. Prevalence and clinical aspects of drug-induced gingival enlargement. Biomedical Research. 2009; 20 (3): 212-218.

  2. Assaggaf MA, Kantarci A, Sume SS, Trackman PC. Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice. Am J Pathol. 2005; 185 (6): 1588-1599.

  3. Guiducci RC, Vieira ML, De Oliveira M, Chaves MG, Lourenço AH, Júnior ET. Tratamiento de la hiperplasia gingival en una escuela odontológica de Brasil. Conceptos generales, diagnóstico y tratamiento. Int J Odontostomat. 2009; 3 (1): 55-60.

  4. Tan H, Gurbuz T, Dagsuyu IM. Gingival enlargement in children treated with antiepileptics. J Child Neurol. 2004; 19 (12): 958-963.

  5. Zeron JA, Sautto M. Agrandamientos gingivales inducidos por medicamentos. Una visión genómica y genética. Revisión de la literatura. Rev Mex Periodontol. 2016; 7 (1): 25-35

  6. Brunet L, Miranda J, Roset P, Berini L, Farre M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with anticonvulsant drugs. Eur J Clin Invest. 2001; 31 (9): 781-788.

  7. Neelathil L, Abraham S. Phenytoin-induced gingival enlargement. BMJ Case Rep. 2014; 2014.

  8. Manzur-Villalobos I, Díaz-Rengifo IA et al. Agrandamiento gingival farmacoinducido: Serie de casos. Univ Salud. 2018; 20 (1): 89-96.

  9. Pilloni A, Camargo PM, Carere M, Carranza FA. Surgical treatment of cyclosporine A- and Nifedipine-Induced gingival enlargement: gingivectomy versus periodontal flap. J Periodontol. 1998; 69 (7): 791-797.

  10. Addy V, McElnay JC, Eyre DG, Campbell N, D’Arcy PF. Risk factors in phenytoin-induced gingival hyperplasia. J Periodontol. 1983; 54 (6): 373-377.

  11. CADIME. Hiperplasia gingival por medicamentos. SEMERGEN. 2007; 33 (5): 273-275.




2020     |     www.medigraphic.com